Clinical trials
Completed Hypertrophy trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 4 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 5 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 32 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | 3 |
| Lindenwood University | 2 |
| Marymount University | 2 |
| Neodyne Biosciences, Inc. | 2 |
| University of Illinois at Urbana-Champaign | 2 |
| Venus Concept | 2 |
| Alexei Wong | 1 |
| Apyx Medical | 1 |
| Bristol-Myers Squibb | 1 |
| California State University, Fullerton | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertrophy | 32 |
| Cicatrix | 4 |
| Cardiomyopathy, Hypertrophic | 3 |
| Hypertrophy, Left Ventricular | 2 |
| Surgical Wound | 2 |
| Acne Vulgaris | 1 |
| Burns | 1 |
| Cardiovascular Diseases | 1 |
| Fibrosis | 1 |
| Heart Diseases | 1 |
Trials
Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.